Creative Medical Technology (NASDAQ:CELZ) said it filed an application to U.S. Food and Drug Administration (FDA) seeking orphan drug designation (ODD) for its ImmCelz (CELZ-100) platform to treat ...
A new therapy for brittle type 1 diabetes, the only treatment currently approved by the U.S. Food and Drug Administration, is available exclusively at UI Health in Chicago. Pancreatic islet cell ...
PHOENIX, March 23, 2023 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a biotechnology company working to revolutionize care through the development of potentially ...
Lantidra is the only treatment currently approved by the U.S. Food and Drug Administration for the treatment of type 1 diabetes. A new therapy for brittle type 1 diabetes, the only treatment currently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback